New drug TRX-100 tested in healthy people for first time
NCT ID NCT06757738
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a single dose of the experimental drug TRX-100 in 66 healthy adults to see if it is safe and how the body processes it. Participants were randomly assigned to receive either TRX-100 or a placebo. The goal was to check for side effects and measure drug levels in the blood, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Scientia Clinical Research
Sydney, Greater Sydney Area, NSW 2031, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New asthma drug candidate enters first human safety tests
- Variety beats repetition: study shows mixing it up improves motor learning
- Pain-Free shots? study tests if preservative is the culprit
- Scientists deliberately infect volunteers with whooping cough to study natural defenses
- Could a nerve channel blocker replace opioids? early study investigates
- New pain pill takes first step: safe in healthy volunteers?